[SY28] シンポジウム28（Clinical, Basic）
甲状腺境界悪性腫瘍の取り扱い

[SY28-2] Changing terminology in the pathological diagnosis of low grade thyroid tumours - Encapsulated Follicular Variant Papillary Carcinoma or NIFT-P

^○Anthony J Gill (Surgical Pathology, University of Sydney)

Anthony Gill holds a personal chair as Professor of Surgical Pathology at the University of Sydney and is a senior staff specialist in anatomical pathology at Royal North Shore Hospital. He is the current chair of the Australian Pancreatic Genome Initiative (APGI). His research efforts are centred on translating advances in knowledge gained at the basic science level into clinically useful diagnostic tests including classical morphology. His work has been central to the widespread acceptance of the new class of neoplasias now known as succinate dehydrogenase deficient (including two new entities: SDH deficient GIST and SDH deficient renal carcinoma). In addition to over 300 original research publications, he has co-authored 10 WHO blue book chapters across three volumes (urological, head and neck and endocrine) and is a member of the WHO consensus panel which met in Lyons France last year to finalize the WHO 2017 classification of endocrine neoplasia.